April 23, 2014

Posts tagged as: statins back to homepage

New Cholesterol Guidelines May Put 13 Million More on Statin Drugs New Cholesterol Guidelines May Put 13 Million More on Statin Drugs

Controversial revised cholesterol-treatment guidelines loosened the definition of who would qualify for statin drug treatment to prevent heart disease, greatly increasing the number of people who would be eligible for treatment. Compared with the older guidelines, the new recommendations would increase the number of US adults eligible for statin therapy from 43.2 million to 56 million, with most of the increase occurring among adults without heart disease.

Perhaps the biggest “sham” of all is that statin drugs, touted as “preventive medicine” to protect your heart health, can actually have detrimental effects on your heart.

Study: Cholesterol-lowering Statin Drugs More Than Double Breast Cancer Risk Study: Cholesterol-lowering Statin Drugs More Than Double Breast Cancer Risk

A recent study found that current users of statins for ten years or longer had an 83% increased risk of invasive ductal carcinoma and a 97% increased risk of invasive lobular carcinoma, when compared to never-users of statins. Among women diagnosed with hypercholesterolemia, current users of statins for ten years or longer had a 104% increased risk of invasive ductal carcinoma and a 143% increased risk of invasive lobular carcinoma.

Even more appalling is the fact that statins have never been shown, in women and most men, to prevent heart attacks and strokes. Nor have statins been shown to significantly prolong a woman or a man’s life. Perhaps women just need to say “No” to a statin prescription.

Vascular Surgeon: Why I’ve Ditched Statins for Good Vascular Surgeon: Why I’ve Ditched Statins for Good

Recent advice proposed by the British NICE – the National Institute for Health and Care Excellence – is advocating that 15 million more people in the UK, most with no history of heart disease, should be taking cholesterol-lowering statin drugs.

Unintentionally, this move may have done more to educate people on the dangers of statin drugs than anything previously published in the alternative media, which has been warning people against the dangers of statin drugs for many years now. Popular doctors in the UK who go against the mainstream medical system in the UK have found willing publishers in the mainstream media in recent days, to publish the other side of the “statin wonder drug” hype that now wants to put almost 25% of the UK population on medications with known and published side effects and little to no benefits.

Suddenly, statin drug whistle blowers in the U.K., such as Dr. Malcolm Kendrick, are getting op-ed pieces in mainstream media. Dr. Kendrick had an article published in the Guardian yesterday: Statins aren’t a wonder drug – The claims made for statins are overblown. They are not a cure for most of the major diseases afflicting western civilisation.

Even mainstream medical doctors are starting to speak out, such as Dr. Kailash Chand, deputy chairman of the British Medical Association. He recently spoke out against the NICE proposal, stating that he also had suffered “awful” muscle pains while taking statins, and that plans to prescribe them to millions more adults will “only benefit drug companies”. (See: Deputy Chairman of British Medical Association Condemns Statins).

Add to this chorus of voices now vascular surgeon Dr Haroun Gajraj, who wrote an op-ed piece in the Telegraph yesterday. The British population is certainly getting an education on the other side of the story regarding statin drugs, but don’t expect to read about this in the pro-Pharma U.S. mainstream media.

Big Pharma Hiding Dangers of Cholesterol-lowering Statin Drugs Big Pharma Hiding Dangers of Cholesterol-lowering Statin Drugs

Are statin drugs the biggest fraud in the history of medicine? Consider the evidence:

“Bad” cholesterol is actually a myth, as cholesterol is essential to life.

The brain contains only 2% of the body’s mass, but 25% of the total cholesterol. Lowering cholesterol by drugs may be contributing to Alzheimer’s.

Lipitor, the best selling-drug in the history of medicine, at one time outsold every other drug on the market with no serious competitors.

Statin drugs are known to have serious side effects, including these that the FDA warns against: liver damage, memory loss and confusion, type 2 diabetes, and muscle weakness.

Now, a group in the U.K. is reporting that the Cholesterol Treatment Trialists’ (CTT) Collaboration in Oxford has an agreement to keep secret much of the information contained in its huge database which holds results from 27 trials of these drugs, nearly all of which were run by a drug company (story below).

This follows the publication last year (2013) of a study published in the Journal of Endocrine and Metabolic Diseases: The Ugly Side of Statins. Systemic Appraisal of the Contemporary Un-Known Unknowns which concluded: “These finding on statin major adverse effects had been under-reported and the way in which they withheld from the public, and even concealed, is a scientific farce.”

And now, in both the USA and the UK, doctors are being encouraged to prescribe even more statin drugs. Fortunately, many doctors are now stepping forward and speaking out against this biggest medical fraud of all time.

Deputy Chairman of British Medical Association Condemns Statins Deputy Chairman of British Medical Association Condemns Statins

What is one way to get doctors to wake up to the dangers of the drugs they prescribe? Put them on the same drugs!

Apparently, this simple technique has worked in the U.K, as leading doctors speaking out against the dangers of statin drugs now include Dr. Kailash Chand, deputy chairman of the British Medical Association. What has caused Dr. Chand to sound the alarm? The Daily Express reports that he has suffered “awful” muscle pains while taking statins, and claims that plans to prescribe them to millions more adults will “only benefit drug companies”.

Dr Chand last night warned that giving the drugs to low-risk patients was “a commercialisation device” and not in their interests. Many experts say it is unnecessary to “medicalise” a problem which could be controlled with simple dietary changes, pointing to a study showing that eating an apple a day cuts cholesterol levels as effectively as taking statins.

Dr Kendrick, who has written a book called The Great Cholesterol Con, said: “I can stop people dying from heart disease by pushing them off the edge of a cliff. They might not like the end result.”

Beta-Blockers Killed 800,000 in 5 Years: “Good Medicine” or Mass Murder? Beta-Blockers Killed 800,000 in 5 Years: “Good Medicine” or Mass Murder?

Most people assume that scientific integrity is somehow assured; that there are safeguards along the way, preventing fraudulent research from harming patients.

Unfortunately, scientific misconduct has become a very serious and widespread problem that threatens the entire paradigm of science-based medicine—unless changes are made.

Again and again, papers assessing the prevalence of scientific fraud and/or the impact this is having shows that the situation is dire and getting worse. In short, we have lost scientific integrity, and without it, “science-based medicine” is just a term without substance.

Conflict of interest is another pervasive problem within the research field, and the featured article highlights a case that contains both.

Beta-blockers are drugs commonly used in the treatment of high blood pressure and congestive heart failure. They work primarily by blocking the neurotransmitters norepinephrine and epinephrine (adrenaline) from binding to beta receptors, thereby dilating blood vessels, which reduces your heart rate and blood pressure.

Until recently, the European Society of Cardiology (ESC) also recommended using beta-blockers in patients undergoing non-cardiac surgery.

A recent article in Forbes Magazine highlights how medical guidelines based on questionable science may have resulted in the death of hundreds of thousands of patients in just a few years:

“Last summer, British researchers provoked concern when they published a paper raising the possibility that by following an established guideline UK doctors may have caused as many as 10,000 deaths each year,” Larry Husten, editorial director of WebMD professional news, writes.

Now, they have gone a step further and published an estimate that the same guideline may have led to the deaths of as many as 800,000 people in Europe over the last five years…

The 800,000 deaths are comparable in size to the worst cases of genocide and mass murder in recent history.”

New Cholesterol Treatment Guidelines Could Double the Number of People on Dangerous Statins—Including Perfectly Healthy People New Cholesterol Treatment Guidelines Could Double the Number of People on Dangerous Statins—Including Perfectly Healthy People

One in four Americans over the age of 45 currently take a statin drug, despite the fact that there are over 900 studies proving their adverse effects, which run the gamut from muscle problems to increased cancer risk.

Now, new treatment guidelines for high cholesterol will likely DOUBLE the number of Americans being prescribed these dangerous drugs, bringing the total to an estimated—and staggering—72 million people!

12 of the 16 panel members of the new guidelines are affiliated with more than 50 different drug companies, many of which have a financial interest in the outcome of this report.

A Pox on Cholesterol Lowering Drugs: Statins Raise Herpes Zoster (Shingles) Risk A Pox on Cholesterol Lowering Drugs: Statins Raise Herpes Zoster (Shingles) Risk

A new study published in the journal Clinical Infectious Diseases reveals an association between statin drug use and increased risk of herpes zoster (shingles). Researchers from St. Michael’s Hospital, Ontario, Canada, conducted a population-based retrospective cohort study of Ontario residents 66 years of age or older, with a study period of thirteen years. They matched 494,651 individuals treated with a statin to an equal number of individuals not treated with one. In the main analysis, the rate of herpes zoster was higher among users of statins relative to nonusers of these drugs.

Dr. Brownstein on New Cholesterol Guidelines: Fugetaboutit Dr. Brownstein on New Cholesterol Guidelines: Fugetaboutit

This week, the new guidelines on preventing heart disease were released by the American Heart Association and the American College of Cardiology. The media reported widely about this. Now, for most people, monitoring LDL-cholesterol and total cholesterol levels is not indicated. If your risk of developing cardiac disease is over 7.5% over a ten year period, then statins are recommended. The risk can be calculated by going to the American Heart Association website and plugging in your cholesterol and HDL-cholesterol numbers as well as your age and whether you smoke or not.

It is hard for me to believe that this is where modern medicine is at. I guess nobody needs to see a health care professional anymore—just put your numbers in and if you have a 10-year heart attack risk of >7.5%,then you must take a statin for the rest of your life. I have one word for this nonsense: fugetaboutit.

People do not get vascular events from a lack of a statin medication. Vascular events occur from a myriad of reasons including eating a poor diet, dehydration, as well as nutrient and hormonal imbalances. Don’t be scared about the media headlines. As you become more educated you will be more comfortable making your health care decisions.

Cholesterol Numbers Meaningless, but FDA to Approve New Class of Cholesterol-lowering Drugs Anyway Cholesterol Numbers Meaningless, but FDA to Approve New Class of Cholesterol-lowering Drugs Anyway

Recently, the latest guidelines (issued by the American Heart Association and the American College of Cardiology) on preventing cardiovascular disease were launched in the US, with a great blare of publicity. The key message was that targets for lowering cholesterol levels are now gone. Don’t worry about cholesterol levels! This is a remarkable U-turn and not only that. What they are saying, in effect, is that lowering LDL is of no use at all. So you might think that the logical next step is that fewer people should be taking statins. Yet weirdly the guidelines now recommend that far more people start to take statins. Perhaps another forty million in the US alone.



Get the news right in your inbox!